Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study

OBJECTIVES: Florbetapir F 18 PET can image amyloid-β (Aβ) aggregates in the brains of living subjects. We prospectively evaluated the prognostic utility of detecting Aβ pathology using florbetapir PET in subjects at risk for progressive cognitive decline. METHODS: A total of 151 subjects who previou...

Full description

Saved in:
Bibliographic Details
Main Authors: Murali Doraiswamy, P., Sperling, Reisa A., Coleman, R. Edward, Johnson, Keith A., Reiman, Eric M., Davis, Mat D., Grundman, Michael, Sabbagh, Marwan N., Sadowsky, Carl H., Fleisher, Adam S., Carpenter, Alan, Clark, Christopher M., Joshi, Abhinay D., Mintun, Mark A., Skovronsky, Daniel M., Pontecorvo, Michael J.
Format: Artigo
Language:Inglês
Published: Lippincott Williams & Wilkins 2012
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3468774/
https://ncbi.nlm.nih.gov/pubmed/22786606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182661f74
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items